167 related articles for article (PubMed ID: 29679261)
1. Accumulation of Mitochondrial DNA Common Deletion Since The Preataxic Stage of Machado-Joseph Disease.
Raposo M; Ramos A; Santos C; Kazachkova N; Teixeira B; Bettencourt C; Lima M
Mol Neurobiol; 2019 Jan; 56(1):119-124. PubMed ID: 29679261
[TBL] [Abstract][Full Text] [Related]
2. Towards the Identification of Molecular Biomarkers of Spinocerebellar Ataxia Type 3 (SCA3)/Machado-Joseph Disease (MJD).
Lima M; Raposo M
Adv Exp Med Biol; 2018; 1049():309-319. PubMed ID: 29427111
[TBL] [Abstract][Full Text] [Related]
3. Selection of Reference Genes for Normalization of Gene Expression Data in Blood of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3 (MJD/SCA3) Subjects.
Ferreira AF; Raposo M; Vasconcelos J; Costa MDC; Lima M
J Mol Neurosci; 2019 Nov; 69(3):450-455. PubMed ID: 31286408
[TBL] [Abstract][Full Text] [Related]
4. Profiling of mitochondrial genomes in SCA3/MJD patients from mainland China.
Yuan H; Yang H; Peng L; Peng Y; Chen Z; Wan L; Wang C; Shi Y; Zhang VW; Tang B; Qiu R; Jiang H
Gene; 2020 May; 738():144487. PubMed ID: 32087274
[TBL] [Abstract][Full Text] [Related]
5. Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease.
Ferreira AF; Raposo M; Shaw ED; Ashraf NS; Medeiros F; Brilhante MF; Perkins M; Vasconcelos J; Kay T; Costa MDC; Lima M
Cells; 2023 May; 12(10):. PubMed ID: 37408238
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial DNA haplogroups and age at onset of Machado-Joseph disease/spinocerebellar ataxia type 3: a study in patients from multiple populations.
Ramos A; Planchat M; Vieira Melo AR; Raposo M; Shamim U; Suroliya V; Srivastava AK; Faruq M; Morino H; Ohsawa R; Kawakami H; Bannach Jardim L; Saraiva-Pereira ML; Vasconcelos J; Santos C; Lima M
Eur J Neurol; 2019 Mar; 26(3):506-512. PubMed ID: 30414314
[TBL] [Abstract][Full Text] [Related]
7. Differential mtDNA damage patterns in a transgenic mouse model of Machado-Joseph disease (MJD/SCA3).
Ramos A; Kazachkova N; Silva F; Maciel P; Silva-Fernandes A; Duarte-Silva S; Santos C; Lima M
J Mol Neurosci; 2015 Feb; 55(2):449-53. PubMed ID: 25001003
[TBL] [Abstract][Full Text] [Related]
8. Global DNA methylation is not elevated in blood samples from Machado-Joseph disease mutation carriers.
Teves L; Vieira Melo AR; Ferreira AF; Raposo M; Lemos C; Bettencourt C; Lima M
Epigenetics; 2024 Dec; 19(1):2368995. PubMed ID: 38900099
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling in the serums of SCA3/MJD patients.
Shi Y; Huang F; Tang B; Li J; Wang J; Shen L; Xia K; Jiang H
Int J Neurosci; 2014 Feb; 124(2):97-101. PubMed ID: 23879331
[TBL] [Abstract][Full Text] [Related]
10. Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease.
Yu YC; Kuo CL; Cheng WL; Liu CS; Hsieh M
J Neurosci Res; 2009 Jun; 87(8):1884-91. PubMed ID: 19185026
[TBL] [Abstract][Full Text] [Related]
11. Patterns of mitochondrial DNA damage in blood and brain tissues of a transgenic mouse model of Machado-Joseph disease.
Kazachkova N; Raposo M; Montiel R; Cymbron T; Bettencourt C; Silva-Fernandes A; Silva S; Maciel P; Lima M
Neurodegener Dis; 2013; 11(4):206-14. PubMed ID: 22832131
[TBL] [Abstract][Full Text] [Related]
12. Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients.
Saute JA; Silva AC; Souza GN; Russo AD; Donis KC; Vedolin L; Saraiva-Pereira ML; Portela LV; Jardim LB
Cerebellum; 2012 Sep; 11(3):771-4. PubMed ID: 22090366
[TBL] [Abstract][Full Text] [Related]
13. Association between Machado-Joseph disease and oxidative stress biomarkers.
Pacheco LS; da Silveira AF; Trott A; Houenou LJ; Algarve TD; Belló C; Lenz AF; Mânica-Cattani MF; da Cruz IB
Mutat Res Genet Toxicol Environ Mutagen; 2013 Oct; 757(2):99-103. PubMed ID: 23994570
[TBL] [Abstract][Full Text] [Related]
14. Glucocerebrosidase gene variants in parkinsonian patients with Machado Joseph/spinocerebellar ataxia 3.
Siebert M; Donis KC; Socal M; Rieder CR; Emmel VE; Vairo F; Michelin-Tirelli K; França M; D'Abreu AC; Bettencourt C; Lima M; Lopes Cendes I; Saraiva-Pereira ML; Jardim LB
Parkinsonism Relat Disord; 2012 Feb; 18(2):185-90. PubMed ID: 22001711
[TBL] [Abstract][Full Text] [Related]
15. Spinocerebellar ataxia type 3/Machado-Joseph disease starting before adolescence.
Donis KC; Saute JA; Krum-Santos AC; Furtado GV; Mattos EP; Saraiva-Pereira ML; Torman VL; Jardim LB
Neurogenetics; 2016 Apr; 17(2):107-13. PubMed ID: 26780339
[TBL] [Abstract][Full Text] [Related]
16. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
[TBL] [Abstract][Full Text] [Related]
17. Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.
da Silva Carvalho G; Saute JA; Haas CB; Torrez VR; Brochier AW; Souza GN; Furtado GV; Gheno T; Russo A; Monte TL; Schumacher-Schuh A; D'Avila R; Donis KC; Castilhos RM; Souza DO; Saraiva-Pereira ML; Torman VL; Camey S; Portela LV; Jardim LB
Cerebellum; 2016 Aug; 15(4):518-25. PubMed ID: 26395908
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease.
Zhou J; Lei L; Shi Y; Wang J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):504-10. PubMed ID: 21743141
[TBL] [Abstract][Full Text] [Related]
19. Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.
Paulson HL
Semin Neurol; 2007 Apr; 27(2):133-42. PubMed ID: 17390258
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Therapies for Machado-Joseph Disease.
Duarte-Silva S; Maciel P
Adv Exp Med Biol; 2018; 1049():369-394. PubMed ID: 29427114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
